BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10799229)

  • 1. Pitfalls of repeat subureteral bovine collagen injections for the endoscopic treatment of vesicoureteral reflux.
    Haferkamp A; Möhring K; Staehler G; Dörsam J
    J Urol; 2000 Jun; 163(6):1919-21. PubMed ID: 10799229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of subureteral collagen injection for endoscopic treatment of vesicoureteral reflux in neurogenic bladder cases.
    Haferkamp A; Möhring K; Staehler G; Gerner HJ; Dörsam J
    J Urol; 2000 Jan; 163(1):274-7. PubMed ID: 10604375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic subureteral glutaraldehyde cross-linked collagen injection for the treatment of secondary vesicoureteral reflux: comparison with primary vesicoureteral reflux in adults.
    Inoue K; Nakamoto T; Usui A; Usui T
    J Urol; 2000 Aug; 164(2):336-9. PubMed ID: 10893579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durability of a single successful endoscopic polytetrafluoroethylene injection for primary vesicoureteral reflux: 14-year followup results.
    Yücel S; Tarcan T; Simşek F
    J Urol; 2007 Jul; 178(1):265-8; discussion 268. PubMed ID: 17499781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of endoscopic subureteral polydimethylsiloxane injection for treatment of vesicoureteral reflux in children: a North American clinical report.
    Herz D; Hafez A; Bagli D; Capolicchio G; McLorie G; Khoury A
    J Urol; 2001 Nov; 166(5):1880-6. PubMed ID: 11586254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up results of vesico-ureteral reflux treated with subureteral collagen injection (SCIN).
    De Grazia E; Cimador M
    Minerva Pediatr; 2000; 52(1-2):7-14. PubMed ID: 10829588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical versus endoscopic correction of vesicoureteral reflux in children with neurogenic bladder dysfunction.
    Engel JD; Palmer LS; Cheng EY; Kaplan WE
    J Urol; 1997 Jun; 157(6):2291-4. PubMed ID: 9146655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antibody class in response to endoscopic subureteral collagen injection in patients with vesicoureteral reflux.
    Inoue K; Nakamoto T; Usui A; Usui T
    J Urol; 2001 Feb; 165(2):555-8. PubMed ID: 11176434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic treatment of primary grades IV and V vesicoureteral reflux in children with subureteral injection of polytetrafluoroethylene.
    Chertin B; De Caluwé D; Puri P
    J Urol; 2003 May; 169(5):1847-9; discussion 1849. PubMed ID: 12686860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic treatment of vesicoureteral reflux in children: our experience and analysis of factors affecting success rate.
    Alkan M; Ciftci AO; Senocak ME; Tanyel FC; Buyukpamukcu N
    Urol Int; 2008; 81(1):41-6. PubMed ID: 18645270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of subureteral bovine collagen injection for the endoscopic treatment of primary vesicoureteral reflux in long-term follow-up.
    Haferkamp A; Contractor H; Möhring K; Staehler G; Dörsam J
    Urology; 2000 May; 55(5):759-63. PubMed ID: 10792096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic subureteral urocol injection for the treatment of vesicoureteral reflux.
    Kajbafzadeh AM; Habibi Z; Tajik P
    J Urol; 2006 Apr; 175(4):1480-3; discussion 1483-4. PubMed ID: 16516028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic subureteral collagen injection for the treatment of vesicoureteral reflux in infants and children.
    Frey P; Lutz N; Jenny P; Herzog B
    J Urol; 1995 Aug; 154(2 Pt 2):804-7. PubMed ID: 7609184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New tissue bulking agent (polyacrylate polyalcohol) for treating vesicoureteral reflux: preliminary results in children.
    Ormaechea M; Ruiz E; Denes E; Gimenez F; Dénes FT; Moldes J; Amarante A; Pioner G; Dekermacher S; de Badiola F
    J Urol; 2010 Feb; 183(2):714-7. PubMed ID: 20022037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parental preferences in the management of vesicoureteral reflux.
    Ogan K; Pohl HG; Carlson D; Belman AB; Rushton HG
    J Urol; 2001 Jul; 166(1):240-3. PubMed ID: 11435878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of collagen for endoscopic correction in complicated vesicoureteral reflux.
    Yu TJ; Chang LC
    Scand J Urol Nephrol; 2007; 41(1):58-65. PubMed ID: 17366104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic treatment of vesicoureteral reflux in patients with myelodysplasia.
    Yokoyama O; Ishiura Y; Seto C; Uchibayashi T; Ohkawa M
    J Urol; 1996 Jun; 155(6):1882-6. PubMed ID: 8618279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are the most powerful determinants of endoscopic vesicoureteral reflux correction? Multivariate analysis of a single institution experience during 6 years.
    Lorenzo AJ; Pippi Salle JL; Barroso U; Cook A; Grober E; Wallis MC; Bägli DJ; Khoury AE
    J Urol; 2006 Oct; 176(4 Pt 2):1851-5. PubMed ID: 16945671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic subureteral collagen injection: are immunological concerns justified?
    Leonard MP; Decter A; Hills K; Mix LW
    J Urol; 1998 Sep; 160(3 Pt 2):1012-6. PubMed ID: 9719266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter survey of endoscopic treatment of vesicoureteral reflux using polytetrafluoroethylene.
    Puri P; Granata C
    J Urol; 1998 Sep; 160(3 Pt 2):1007-11; discussion 1038. PubMed ID: 9719265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.